Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma
JAMA Surgery · 2023
DOI: 10.1001/jamasurg.2022.5697 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Surgery, 2023. Verfasst von Fabrizio Di Benedetto und 17 weiteren Autor:innen. Beteiligte Einrichtung: Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Modena, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Robotic Surgical Procedures, Laparoscopy. Die Arbeit wurde bisher 150-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Long-term oncologic outcomes of robotic surgery remain a hotly debated topic in surgical oncology, but sparse data have been published thus far.
Objective
To analyze short- and long-term outcomes of robotic liver resection (RLR) for hepatocellular carcinoma (HCC) from Western high-volume centers to assess the safety, reproducibility, and oncologic efficacy of this technique. Design, Setting, and Participants This cohort study evaluated the outcomes of patients receiving RLR vs open liver resection (OLR) for HCC between 2010 and 2020 in 5 high-volume centers. After 1:1 propensity score matching, a group of patients who underwent RLR was compared with a validation cohort of OLR patients from a high-volume center that did not perform RLR. Main Outcomes and Measures A retrospective analysis was performed of prospectively maintained databases at 2 European and 2 US institutions of patients who underwent RLR for HCC between January 1, 2010, and September 30, 2020. The main outcomes were safety and feasibility of RLR for HCC and its oncologic outcomes compared with a European OLR validation cohort. A 2-sided P < .05 was considered significant.
Results
The study included 398 patients (RLR group: 125 men, 33 women, median [IQR] age, 66 [58-71] years; OLR group: 315 men, 83 women; median [IQR] age, 70 [64-74] years), and 106 RLR patients were compared with 106 OLR patients after propensity score matching. The RLR patients had a significantly longer operative time (median [IQR], 295 [190-370] minutes vs 200 [165-255] minutes, including docking; P < .001) but a significantly shorter hospital length of stay (median [IQR], 4 [3-6] days vs 10 [7-13] days; P < .001) and a lower number of admissions to the intensive care unit (7 [6.6%] vs 21 [19.8%]; P = .002). Incidence of posthepatectomy liver failure was significantly lower in the RLR group (8 [7.5%] vs 30 [28.3%]; P = .001), with no cases of grade C failure. The 90-day overall survival rate was comparable between the 2 groups (RLR, 99.1% [95% CI, 93.5%-99.9%]; OLR, 97.1% [95% CI, 91.3%-99.1%]), as was the cumulative incidence of death related to tumor recurrence (RLR, 8.8% [95% CI, 3.1%-18.3%]; OLR, 10.2% [95% CI, 4.9%-17.7%]). Conclusions and Relevance This study represents the largest Western experience to date of full RLR for HCC. Compared with OLR, RLR performed in tertiary centers represents a safe treatment strategy for patients with HCC and those with compromised liver function while achieving oncologic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Modena, Italy.
- Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
- Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori di Milano, Milan, Italy.
- Swiss Hepato-Pancreato-Biliary and Transplantation Center, Department of Surgery, University Hospital Zurich, Zurich, Switzerland.
- Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Weill Cornell Medical College, New York, New York.
- Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
Zitieren
APA
Di Benedetto, F., Magistri, P., Di Sandro, S., Sposito, C., Oberkofler, C., Brandon, E., Samstein, B., Guidetti, C., Papageorgiou, A., Frassoni, S., Bagnardi, V., Clavien, P. A., Citterio, D., Kato, T., Petrowsky, H., Halazun, K. J., Mazzaferro, V., & Robotic HPB Study Group (2023). Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma. JAMA Surgery. https://doi.org/10.1001/jamasurg.2022.5697
Vancouver
Di Benedetto F, Magistri P, Di Sandro S, Sposito C, Oberkofler C, Brandon E, et al. Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma. JAMA Surgery. 2023. doi:10.1001/jamasurg.2022.5697
BibTeX
@article{DiBenedetto2023,
author = {Di Benedetto, Fabrizio and Magistri, Paolo and Di Sandro, Stefano and Sposito, Carlo and Oberkofler, Christian and Brandon, Ellie and Samstein, Benjamin and Guidetti, Cristiano and Papageorgiou, Alexandros and Frassoni, Samuele and Bagnardi, Vincenzo and Clavien, Pierre-Alain and Citterio, Davide and Kato, Tomoaki and Petrowsky, Henrik and Halazun, Karim J and Mazzaferro, Vincenzo and Robotic HPB Study Group, Robotic HPB Study Group},
title = {Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma},
journal = {JAMA Surgery},
year = {2023},
doi = {10.1001/jamasurg.2022.5697}
}
EUVIMED